Patient experience of care remains an important indicator of health care quality. Although studies show care experiences are associated with health outcomes for some conditions, the situation for cancer is unclear. New datasets on cancer patients in the US, Canada, and UK linking information on experiences and survival may enable an exploration of any association. This review aimed to identify studies linking any aspect of cancer patients' experiences to their survival, to inform future analyses. We performed a systematic review using Medline database from January 1998 until March 2018. The settings included outpatient oncology clinics, primary care, hospitals, and cancer centres. The participants included adult patients from different demographic groups. 16 Studies (ten observational, two clinical trials, two qualitative, and two consecutive case series) describing a wide range of settings, populations and methods met our inclusion criteria. Patients' experiences were mostly linked to survival in quantitative studies. Satisfaction with care and psychosocial support were the aspects of experience associated with survival. Although positive associations between experience and survival were more common, negative and lack of association findings were also reported. Overall, there was no agreement on the strength, direction of the association, and the type of measurements to use. In conclusion, a wide range of studies suggest a relationship may exist between patients' experiences of cancer care and their survival. However, this relationship is complex and methodological challenging to study. Future research should carefully consider different aspects of patient experience and care and the way in which they may affect cancer survival.
Introduction
Patient-centred care is now recognised as an essential component of high quality healthcare. 1 Patient experience is an important measure and interpretation of how patientcentred care principles and practice are perceived by patients receiving health care. 2 A considerable international literature on patient experience has grown in response to the increasing emphasis on and measurement of patients' experiences in healthcare systems. [3] [4] [5] Wolf and colleagues point out that "patient experience reflects occurrences and events that happen independently and collectively across the continuum of care". 6 The link between patient experience and health outcomes has been investigated in many different healthcare settings. 7 Several studies across a range of health conditions and different populations have documented associations between patient experience and care effectiveness, 8, 9 patient safety, 10 and mortality. 11 Cancer outcomes are influenced by cancer type, stage of disease, comorbid conditions at diagnosis, and the quality of cancer care the patient receives. 12 The possibility of an association between patient experience and survival has not often been investigated in a cancer care setting. Sociodemographic and systemic variations in patient experience with cancer care have been documented in several studies from the United States 13, 14 and England. [15] [16] [17] [18] [19] Some of the factors associated with poorer experience such as lower socioeconomic status are also associated with poorer outcomes raising the question of whether an independent association exists between patients' experiences of cancer care and their survival.
Several systematic reviews have focused on cancer patient experience. Sanders and others 20 conducted a review to investigate the available instruments used to measure the cancer patient experience of health care. They found that there is a lack of studies measuring cancer patient experience in a systematic and consistent way. 20 Mollica and colleagues performed a scoping review of cancer patient experience, considering only the core domains of Services Consumer Assessment of Healthcare Providers and Systems (CAHPS) -a patient experience instrument used widely in the USA, that summarized the literature and identified possible future directions for research. 21 Their review identified a gap in the research literature regarding Patient Experience Journal, Volume 6, Issue 1 -2019 the relationship between cancer care experience and survival. Thus, the aim of this study was to search the medical literature systematically to determine how patients' experiences of cancer care have been linked to survival. We hoped that this would inform 1) directions for future research in this area and 2) the development of analyses of the recently available linked patient experience and patient survival databases. 22, 23 
Method and approach
Patient experience is a term that refers to different dimensions of the interaction between patients and the healthcare system and has not yet been recognized as a subject heading in health science databases. Previous systematic reviews on patient experience have also used different dimensions to extract different types of literature. 10, 21 We chose to use the patient experience dimensions presented by Doyle and colleagues since they combined patient experience dimensions from the Institute of Medicine, Picker Institute, and National Institute for Health and Care Excellence (NICE). 10 We identified possible words and terms that might denote literature on dimensions of patient experience ( Table 1 and Box 1). We used cancer survival as the outcome, and a range of different terms to extract possible relevant literature ( Table 1) . We limited this first review to Medline due to the complexity of duplicating the same terms in other databases and assumed that most of quantitative articles investigating survival would be indexed in Medline. After combining these terms together, and using the Medline database, we identified 1830 papers that were published between January 1998 and March 2018. Titles and abstracts for all 1830 articles were first read by one reviewer (AS) who excluded 1683 as not at all relevant. The remaining 147 were read and a shortlist of 26 full text articles prepared ( Figure 1 ).
In addition, since patient experience is an emerging research field, we considered eligible papers that have been referred to in the following popularly cited articles that linked patients' experiences to their health outcomes, 8, 9 in the scoping review about cancer experience with care, 21 and in a popular systematic review that linked patients' experience to clinical safety and effectiveness across many health conditions including several types of cancer. 10 Following that, we used Google Scholar features, "Cited by" and "Related Articles", to review the citation histories of these popular articles to consider any additional paper that has linked patients' experiences to cancer survival ( Figure 1 ). By doing so, we found an additional nine articles that met our inclusion criteria. The preliminary shortlist of eligible research papers were initially chosen by the first reviewer (SA), and these were read independently by another reviewer (ED) and discussed with a third (ML). The first reviewer then extracted the following information (type of study, sample size, country, setting, study aim, cancer type, unit of analysis, patient experience aspect and method used, primary outcomes and method used, and results) from each study and these aspects were independently assessed by reviewers (ED, ML) to determine the final eligible articles. In addition, although many assessment tools were available, we chose the Effective Public Health Practice Project Assessment Tool 25 to assess the quality of the included quantitative studies due to the variety in design of included studies (Appendix 1).
We included studies that linked any aspect of patient experience with cancer survival. This included studies where the experience was reported by patients, doctors, GPs, or extracted from healthcare systems records. Patient
Reported Outcomes Measures (PROM) studies were excluded on the basis that they do not ask questions about patient experiences, but rather about symptoms and outcomes. All types of studies such as cross sectional, cohort and case control studies that used validated tools or specifically developed interviews to measure or assess patient experience dimensions and linked that to a measure of cancer survival were included. The studies were categorized into four groups, based on their main aims and how they linked patients' experiences to cancer survival: (1) preferences for information about cure or treatment, (2) psychosocial support (3) a care system or team intervention, and (4) patient satisfaction.
Results
A total of 16 journal articles met the inclusion criteria including 11 observational studies, 26, 27, 36, [28] [29] [30] [31] [32] [33] [34] [35] one quantitative content analysis, 37 two clinical trials, 38, 39 and two consecutive case series. 40, 41 The included studies varied widely in methods, population and findings. Table 2 (found at the end of the article) summarizes the study aims, study population, methods, patients experience aspects, and study outcomes.
Preferences for information about cure or treatment
Two studies -one cohort 34 and one cross sectional 33 focused on patients' expectations for cancer cure, their treatment preference, relations with oncologists and how they perceived quality of care to be. Gleason et al examined whether lung, colorectal, breast, lymphoma, head and neck, liver, and leukaemia cancer patients' expectations for cure influence their decisions to follow treatment recommendations and whether these are affected by oncologist-patient alliance. 33 The authors found that patients who expected a cure were more likely to report an intention to follow oncologists' treatment recommendations. 33 Additionally, Rose and colleagues focused on the difference between older and middle-aged late-stage cancer patients in terms of care preference, relations with oncologist, perceived quality of life and estimation of survival. 34 This study concluded that both middle-aged and older patients and their physicians had different perspectives regarding perceived quality of life, physician estimation for patents' survival, and patient's estimation for their survival. 34 In addition, the majority of patients in both groups had treatment goals of relieving pain or discomfort. 34
Psychosocial support
Four studies (one clinical trial, 39 two observational studies, 35, 36 and one qualitative study 37 ) focused on psychosocial support and patients' survival. Burns et al investigated whether emotional support was predictive of survival among patients with incurable breast, lung, and gastrointestinal, prostate, and haematological cancer. They found that survival (follow-up 36 months) was significantly shorter among those with two to three confidants than among those with more or fewer confidants (p=0.031). They also found emotional support to be an independent prognostic indicator of survival. 35 Guo et al determined the benefits of psychosocial interventions for breast, lung, cervical, endometrial cancer patients who were undergoing radiotherapy 39 . Although no significant difference between cases and controls in terms of survival was found, the psychological intervention significantly reduced symptoms of anxiety (p < 0.05) and depression (p < 0.05), as well as improved elements of quality of life such as global health status (p < 0.05) in the intervention group. 39 In addition, in a qualitative analysis, Buis and colleagues analysed 3717 posts on the internet, made by patients with lung, pancreatic, melanoma, and thyroid cancer, to determine how emotional and informational support contents differ in online communities for cancers with high and low five-year survival. 37 Within the posts containing social support content, high-survival cancer communities had more content including emotional support (75%) than lowsurvival communities (66%). By contrast, low-survival communities had more informational content (46%) than high survival communities (36%). 37 Finally, Cunningham and colleagues focused on the variation in psychological responses to the diagnosis of life-threatening cancer and whether that is related to survival in several types of cancers. 36 Even though this study had a limited sample size (n=22), patients who had a lower psychological score had a statistically significant median survival of 1.29 years while those with higher psychological score had median survival of 2.85 years. The authors attributed this to psychological self-help activities such as relaxation, meditation, and spiritual activities. 36
Health care system and team intervention
Two studies (one cross sectional study 32 and one nonrandomised clinical trial 38 ) focused on the cancer care system, or team interventions and their association with cancer survival. McCarthy and colleagues investigated various aspects of the performance of breast, colorectal, lung and prostate cancer services and whether they were related to survival at the hospital level or specialist services level. 32 They combined five different datasets including waiting time, compliance with standards, cancer patient experience survey, hospital routinely collected data, and cancer survival data. 32 Their analysis showed that higher breast cancer one-year survival (p=0.04) and lung cancer five-year survival (p=0.014) at cancer network level was associated with higher overall dissatisfaction scores. 32 In addition, Daly and colleagues conducted a nonrandomized clinical trial to evaluate the effects of interdisciplinary cancer support team on quality of life and quality of care among patients with advanced colorectal, lung, and gynaecologic cancers. 38 The study found no significant difference between cases and controls in quality of care; but that the five-year survival probability was the most significant effect on quality of care outcomes (p = 0.04). 38
Patient satisfaction
Eight studies, (five cross sectional studies, [26] [27] [28] 30, 31 two consecutive case series, 40,41 and one prospective cohort study 29 ), were conducted at Cancer Treatment Centres of America hospitals, and focused on the association between patient satisfaction and survival. This research assessed different types of patient satisfaction including patient satisfaction with service quality and patient satisfaction with quality of life. After controlling for variables such as cancer stage at diagnosis, previous treatment history, and treatment location, patients who had higher satisfaction Patient Experience Journal, Volume 6, Issue 1 -2019 67 with their service quality had a lower risk of mortality than those with low satisfaction score in the following cancers: colorectal (hazard ratio (HR) = 0.74; 95% CI: 0.58-0.95; p = 0.02), 27 pancreatic (HR= 0.63; 95% CI: 0.51-0.79; p = 0.001), 31 breast (HR= 0.71; 95 % CI 0.57-0.87; p=0.001), 28 and non-small cell lung (HR = 0.71; 95% CI: 0.60-0.85; p < 0.001). 29 Later, Gupta and colleagues added self-rated health as an independent variable and examined the same association in non-small cell lung 30 and prostate cancers independently. 26 They found that self-rated-health was significant in predicting survival in non-small cell lung cancer (HR = 0.75; 95% CI: 0.57 to 0.99; p=0.04) and prostate 26 cancer (HR= 0.25; 95 % CI: 0.11-0.58; p=0.001). Thus, self-rated-health confounded the relationship between patient satisfaction and survival in non-small cell lung cancer 30 and replaced patient satisfaction in prostate cancer 26 as a predictor of survival.
In two other studies conducted at the same cancer centre, Lis and colleagues assessed whether patient satisfaction with quality of life can predict survival in advanced colorectal 41 and pancreatic cancers. 40 After controlling for cancer stage at diagnosis (in both) and previous treatment history (only in colorectal), baseline patient satisfaction with quality of life was prognostic for survival in advanced colorectal cancer (p=0.0003), 41 but not in pancreatic cancer (p=0.053). 40 Overall, findings from these studies support the importance of assessing the relationship between patient satisfaction, self-rated health, and quality of life measures in cancer patent experience. Yet, the inconsistency in the results is puzzling. It might be a result of differing effects of type of cancer, pathways of possible influence for patient experience, care offered at different treatment centres, and different measuring instruments used in the studies. All of these possibilities emphasize the need for a systematic and consistent way to assess the association between cancer patient experience and subsequent survival.
Discussion
The aim of this study was to systematically review the literature to determine how cancer patient experience has been linked to cancer survival. We hoped to inform the direction of research in this area and analysis of the recently available linked patient experience and patient survival databases. Overall, this review revealed a variety of different methods and perspectives on how cancer patients' experiences were linked to survival across different types of cancer. Patients' satisfaction, psychosocial support, satisfaction with quality of life were the most common aspects of patient experience found to be associated with survival in the literature. The studies we included in our review showed positive, negative or lack of association cancer patient experience and subsequent survival. Thus, these studies suggest a relation exists between patients' experiences of cancer care and survival, but it is a complex and methodological challenging one to study.
Previous systematic reviews have identified several gaps in the cancer patient experience research field. Sanders et al found that there is a lack of studies measuring cancer patient experience in systematic and consistent ways. 20 We found a wide range of methods, settings, and population used to measure cancer patients experience and to link it to subsequent survival. Moreover, Mollica et al conducted a review to summarize the cancer patient experience literature, indicate research gaps, and provide future research directions. 21 They identified a gap in research examining relationships between cancer experience and survival. Our study contributes to closing this gap by finding that cancer patients' experiences have been linked to survival in a number of studies and revealing a complex and challenging relationship to unpick. In addition, Doyle et al demonstrated a positive association between patient experience and patient safety and clinical effectiveness across a wide range of disease areas including several types of cancer. 10 Several studies included in our review suggested a positive association between cancer patient experience and patient survival. However, as our review shows a clear heterogeneity across all aspects of linking cancer patient experience with subsequent survival, not all of these studies gave a clear overall indication of the magnitude of any observed association.
Our findings show the difficulty of determining the association between patient experience and survival. While the finding is a novel one for cancer care settings, several studies in other health settings have raised concerns that any possible association between patient experience and health outcomes may be biased by patient characteristics, or affected by reverse causation or confounded by factors within the healthcare system or related to the patient's health situation. 7, 42, 43 These issues were found in several studies included in this review. For example, the conclusion that cancer survival can be predicted by measuring patient self-rated health or patient satisfaction with services quality or with quality of life was contradicted by findings within studies conducted by the same research group. [26] [27] [28] [29] [30] [31] 40, 41 Despite the different cancer types in these studies, such a contradiction in the final conclusions demonstrates the importance of using appropriate methodological tools when assessing association between patient experience and health outcomes in cancer setting as the case in other health settings.
The present study has several strengths. First, it is, to our knowledge, the first study that examines how cancer patient experience has been linked to cancer survival. Second, using the methods presented by Doyle et al , 10 we extended the patient experience dimensions to include those presented by the Picker Institute, NICE to catch all dispersed terms. In addition, since the association between patient experience and health outcome is an emerging field and not well established in the literature, we included Patient Experience Journal, Volume 6, Issue 1 -2019 relevant articles from similar systematic reviews and popular studies in the field to make sure we included all relevant studies in the field.
However, our study is subject to several limitations. This systematic review was limited to English language articles in Medline database and did not include other medical databases such as CINAHL, which might include some eligible studies. This exclusion was due to the complexity and lack of uniformity of the MeSH terms for patient experience dimensions in different medical databases. This is an area for future research to review the current used MeSH terms for measuring patient experience given the importance of measuring these elements in current research. Second, some of the included studies in our review had several methodological limitations within them including sample size, absence of a control group and not considering reverse causation. For example, several of the patient satisfaction studies we included reported contradictory results across several types of cancer and needed an appropriate reverse causation analysis using systematic and consistent instruments. However, we decided to include them since the main aim of this study is to examine how patients experience have been linked to survival in the literature, not to draw a conclusion on the strength and direction of association between cancer patient experience and cancer survival. Finally, we cannot exclude the possibility of publication bias for significant positive or negative association findings.
Conclusion
The possible association between patient experience with cancer care and subsequent outcomes continues to emerge as an important topic. The availability of the UK 22 , Canada 44 , and US 23 datasets that contain information on both cancer patients' experiences and their survival status will enable researchers to explore such an association. This review highlights the methodological complexity of determining a possible relationship between cancer patient experience and subsequent survival. While future research is recommended to examine the strength and direction of this association, appropriate conceptual and methodological consideration is warranted before studying or drawing a conclusion on this association. Gupta, et al (2013 
